Gf Fund Management Co. Ltd. Cure Vac N.V. Transaction History
Gf Fund Management Co. Ltd.
- $5.51 Trillion
- Q3 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Cure Vac N.V. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 4,844 shares of CVAC stock, worth $25,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,844
Previous 5,744
15.67%
Holding current value
$25,576
Previous $31.2 Million
16.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CVAC
# of Institutions
108Shares Held
22.5MCall Options Held
124KPut Options Held
77.1K-
Glazer Capital, LLC New York, NY4.55MShares$24 Million0.82% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.3MShares$12.1 Million0.78% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$11.9 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X01.71MShares$9.04 Million0.01% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.28 Million10.6% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $990M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...